We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+21.23%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
10 Year Est. Return
AUM
$248M
AUM Growth
+$27.4M
Cap. Flow
-$3.33M
Cap. Flow %
-1.34%
Top 10 Hldgs %
69.93%
Holding
98
New
13
Increased
15
Reduced
10
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Materials 21.4%
3 Financials 15.49%
4 Communication Services 11.05%
5 Industrials 1.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSK icon
76
FS KKR Capital
FSK
$3.04B
$42.9K 0.02%
2,875
BX icon
77
Blackstone
BX
$106B
$35.9K 0.01%
210
DHR icon
78
Danaher
DHR
$138B
$35.7K 0.01%
180
DOW icon
79
Dow Inc
DOW
$20.8B
$27.7K 0.01%
1,206
OXY icon
80
Occidental Petroleum
OXY
$54.6B
$26.4K 0.01%
663
TMO icon
81
Thermo Fisher Scientific
TMO
$208B
$21.8K 0.01%
45
UNH icon
82
UnitedHealth
UNH
$379B
$19.7K 0.01%
57
CRM icon
83
Salesforce
CRM
$142B
$18.2K 0.01%
77
KD icon
84
Kyndryl
KD
$2.81B
$12.9K 0.01%
428
STWD icon
85
Starwood Property Trust
STWD
$6.15B
$7.75K ﹤0.01%
400
GEHC icon
86
GE HealthCare
GEHC
$27.8B
$3.75K ﹤0.01%
50
WAB icon
87
Wabtec
WAB
$50.8B
$1.2K ﹤0.01%
6
AUTL
88
Autolus Therapeutics
AUTL
$389M
-270,000
Closed -$616K
AXSM icon
89
Axsome Therapeutics
AXSM
$12.3B
-6,000
Closed -$626K
COLL icon
90
Collegium Pharmaceutical
COLL
$1.15B
-23,511
Closed -$695K
ESGR
91
DELISTED
Enstar Group
ESGR
-7,500
Closed -$2.52M
FSBW icon
92
FS Bancorp
FSBW
$323M
-1,460
Closed -$57.5K
INZY
93
DELISTED
Inozyme Pharma
INZY
-666,204
Closed -$2.66M
IWP icon
94
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
-695
Closed -$96.4K
KO icon
95
Coca-Cola
KO
$362B
-2,000
Closed -$142K
MYGN icon
96
Myriad Genetics
MYGN
$515M
-180,000
Closed -$956K
ATYR
97
aTyr Pharma
ATYR
$48M
-50,367
Closed -$255K

Similar funds

David M. Knott Jr's Q3 2025 Portfolio in Review

As of Q3 2025, David M. Knott Jr held 98 positions worth $248M, up 12% from $221M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

David M. Knott Jr's Q3 2025 filing shows 13 new, 15 increased, 10 reduced and 10 closed positions. Its largest new stake was Rezolute: 275,000 shares worth $2.58M. The largest sale was Calumet Specialty Products, an estimated $7.4M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2025 buy was Rezolute: 275,000 shares worth $2.58M.
  • David M. Knott Jr added most to Syndax Pharmaceuticals in Q3 2025, an estimated $985K increase.
  • David M. Knott Jr's biggest Q3 2025 reduction was Calumet Specialty Products, cutting an estimated $7.4M.
  • David M. Knott Jr fully exited Inozyme Pharma in Q3 2025, selling an estimated $2.66M.
  • David M. Knott Jr's ten largest holdings make up 70% of its $248M portfolio in Q3 2025.
  • David M. Knott Jr opened 13 new positions and closed 10 in Q3 2025.
  • David M. Knott Jr's portfolio value rose 12% quarter-over-quarter to $248M.

Based on David M. Knott Jr's 13F filing for Q3 2025, filed 12 Nov 2025.